Down-regulation of MET, the receptor for hepatocyte growth factor

Oncogene. 2001 May 17;20(22):2761-70. doi: 10.1038/sj.onc.1204475.


The ligand-dependent degradation of activated tyrosine kinase receptors provides a means by which mitogenic signalling can be attenuated. In many cell types the ligand-dependent degradation of the tyrosine kinase receptor Met is completely dependent on the activity of the 26S proteasome (Jeffers et al., 1997b). We now show that degradation also requires trafficking to late endosomal compartments and the activity of acid dependent proteases as determined by the effects of a dominant negative form of dynamin (K44A) and a vacuolar-ATPase inhibitor, concanamycin. We show that in the presence of the proteasome inhibitor lactacystin, Met fails to redistribute from the plasma membrane to intracellular compartments. This observation is most consistent with the interpretation that proteasome activity is required for Met internalization and only indirectly for its degradation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcysteine / analogs & derivatives*
  • Acetylcysteine / pharmacology*
  • Cysteine Proteinase Inhibitors / pharmacology*
  • Down-Regulation
  • Endocytosis
  • Endosomes / metabolism
  • HeLa Cells / drug effects
  • HeLa Cells / metabolism
  • Hepatocyte Growth Factor / metabolism
  • Hepatocyte Growth Factor / pharmacology
  • Humans
  • Proto-Oncogene Proteins c-met / metabolism*


  • Cysteine Proteinase Inhibitors
  • lactacystin
  • Hepatocyte Growth Factor
  • Proto-Oncogene Proteins c-met
  • Acetylcysteine